Saccade GTM brain

Saccade offers a consumer brain performance assessment using eye movements and blood markers while researching early Alzheimer's detection.

category

Brain health assessment

market profile

  • text: The current site presents an at-home cognitive eye test and blood panel alongside a separate Alzheimer's research study.
  • text: Digital cognitive assessment alternatives span clinician screening tools and eye-tracking research platforms, with different intended uses and evidence.

personas

  • title: Health-conscious consumer
    pains:
    • Wants a clearer picture of attention and cognitive performance without arranging multiple appointments.
    • Needs understandable results and guidance rather than a list of lab values.
  • title: Longevity clinic medical director
    pains:
    • Wants practical ways to discuss cognitive performance and follow-up with patients.
    • Must assess the evidence, clinical utility and intended use of emerging tests.
  • title: Alzheimer's research participant or caregiver
    pains:
    • Family history or lived experience motivates interest in research on earlier detection.
    • Needs clarity about study participation and what results can and cannot establish.

icp

  • text: Consumers willing to pay for accessible brain performance and wellness assessments, with availability subject to confirmation.
  • text: Longevity practices seeking cognitive assessment options and able to review clinical evidence and referral workflows.
  • text: Research cohorts including people living with Alzheimer's or with family history who can attend follow-up.

message pillars

  • text: Combine cognitive eye measurements with blood markers in a convenient assessment.
  • text: Make results understandable and offer clinician discussion.
  • text: Offer an avenue to participate in Alzheimer's research.

objections

  • objection: Does this test diagnose or rule out Alzheimer's?
    response: Ask for the intended use and evidence; distinguish the consumer assessment from investigational Alzheimer's research and do not present it as a diagnosis.
  • objection: How actionable are the findings?
    response: Review the report and any follow-up with a qualified clinician, including the limitations of the individual measures.
  • objection: What does testing cost and where is it available?
    response: Request current pricing and eligibility directly; the pages reviewed do not state a price.

competitors

  • name: Cognivue
    website: https://www.cognivue.com/
    why: Offers clinician-oriented digital cognitive screening, with different indications.
  • name: ViewMind
    website: https://www.viewmind.com/
    why: Uses eye tracking to assess cognitive function, notably for research.
  • name: Neurotrack
    why: Offers digital cognitive assessments for screening and tracking.

influencers

  • name: Shreyas Bhardwaj
    url: https://nitter.rdrama.net/shreyasbhardwj
    why: Founder discussing Saccade and its early detection research.

keywords

  • brain health assessment
  • cognitive performance test
  • eye tracking cognitive assessment
  • Alzheimer's early detection research
  • at home brain health test
  • longevity cognitive testing

voice

  • Consumer-friendly and optimistic
  • Clinician-informed
  • Focused on measurable performance

signals

  • text: A consumer seeks baseline cognitive performance and repeat measurement.
  • text: A longevity clinic is expanding brain health services or research partnerships.

stack

  • VR
  • eye tracking
  • machine learning

pricing

model: unknown

motion

unknown

channels

  • website
  • X

confidence

medium

Founders

  • name: Shreyas Bhardwaj
    title: Founder/CEO
    role: CEO
    bio: Founder at Saccade. Prev built medical devices for hospitals; soft robotics researcher

Back to YC companies